Sports nutrition company All American EFX is proud to announce the upcoming release of Joint Rehab™. This innovative formula is designed to help athletes maintain their active lifestyle and intense training schedule. It contains a double-patented, dietary ingredient called Kre-Celazine™ (Kre-Alkalyn® a patented, buffered creatine monohydrate and esterfied fatty acids).

Requiring just two capsules per day, All American EFX findings show that Joint Rehab™ works particularly well at relieving soreness and stiffness of the neck, shoulders and extremities that result due to an active lifestyle. It works by fortifying the structural lipids of the cell membranes providing nutritional support that enables cells to quickly repair and regenerate. The kit also contains a free tube of Joint Rehab™ cream to be used for site specific pain.

Joint Rehab™ (when combined with a resistance training program) also contains compounds that function to renew, strengthen and protect the joints by enhancing muscle growth to create a stronger outer structure for skeletal and connective tissue. Formulated with Kre-Alkalyn®, the world's only patented pH-Correct creatine gives Joint Rehab™ an alkalizing effect and contributes to the overall health of the human body at the cellular level.

The Test Results Are In... Joint Rehab™ Works! A double-blind study using the key compound found in Joint Rehab™, Kre-Celazine®, was conducted on 35 controlled subjects (21 males, 14 females), to determine its effectiveness at reducing site-specific joint and muscle-related inflammation/pain related to everyday activities.

Test subjects experiencing isolated areas of joint/muscle inflammation/pain, were divided into 2 groups: Group A was assigned four capsules of Kre-Celazine® daily, Group B, an equal number of placebo capsules. The duration of the double-blind study was 30 days. Each participant kept a "Pain Journal" to help assess the effectiveness of the compound.

In Group A approximately 100% of ankle/foot pain, 80 - 85% of neck/ shoulder/elbow/wrist and hand pain, 71% of knee pain respondents (the Kre-Celazine® group) rated their "compound" as good or better than a prescription product in its ability to reduce/eliminate discomfort.

(Reference: Golini J, Beeson M, Angersbach D, Moore J, Holl P, Amicone C, Jones W. A Single-Center, Double-Blind Placebo Controlled Study to Evaluate the Efficacy of Kre-Celazine®, an Oral Buffered Creatine-Cetylated Fatty Acid Compound, in its Ability to Reduce Site-specific Inflammation and Pain. JANA. 2009; 12(1):20-25.)